These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20437017)

  • 21. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree.
    Haseltine JM; Rimner A; Gelblum DY; Modh A; Rosenzweig KE; Jackson A; Yorke ED; Wu AJ
    Pract Radiat Oncol; 2016; 6(2):e27-33. PubMed ID: 26577006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic body radiotherapy for oligometastatic lung tumors.
    Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Hepel JT; Leonard KL; Safran H; Ng T; Taber A; Khurshid H; Birnbaum A; ; Wazer DE; DiPetrillo T
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1021-1027. PubMed ID: 27745983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function.
    Ishihara T; Yamada K; Harada A; Yukiue H; Tanahashi M; Niwa H; Matsui T; Yokomura K; Ejima Y; Sasaki R
    Acta Oncol; 2018 Sep; 57(9):1232-1239. PubMed ID: 29722594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits.
    Song DY; Benedict SH; Cardinale RM; Chung TD; Chang MG; Schmidt-Ullrich RK
    Am J Clin Oncol; 2005 Dec; 28(6):591-6. PubMed ID: 16317270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer.
    Videtic GMM; Reddy CA; Woody NM; Stephans KL
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):436-442. PubMed ID: 34048817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic body radiation therapy for centrally located lung lesions.
    Joyner M; Salter BJ; Papanikolaou N; Fuss M
    Acta Oncol; 2006; 45(7):802-7. PubMed ID: 16982543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central Lung Tumor.
    Rim CH; Yoon WS; Park S
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674184
    [No Abstract]   [Full Text] [Related]  

  • 30. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
    Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
    Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SBRT for centrally localized NSCLC - What is too central?
    Roesch J; Panje C; Sterzing F; Mantel F; Nestle U; Andratschke N; Guckenberger M
    Radiat Oncol; 2016 Dec; 11(1):157. PubMed ID: 27912764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic Body Radiotherapy for Large (> 5 cm) Non-Small-Cell Lung Cancer.
    Peterson J; Niles C; Patel A; Boujaoude Z; Abouzgheib W; Goldsmith B; Asbell S; Xu Q; Khrizman P; Kubicek GJ
    Clin Lung Cancer; 2017 Jul; 18(4):396-400. PubMed ID: 28040379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
    Woody NM; Stephans KL; Marwaha G; Djemil T; Videtic GM
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):325-31. PubMed ID: 25841625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules.
    Owen D; Olivier KR; Mayo CS; Miller RC; Nelson K; Bauer H; Brown PD; Park SS; Ma DJ; Garces YI
    Radiat Oncol; 2015 Feb; 10():43. PubMed ID: 25889747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
    Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-Irradiation of Locoregional NSCLC Recurrence Using Robotic Stereotactic Body Radiotherapy.
    Ceylan C; Hamacı A; Ayata H; Berberoglu K; Kılıç A; Güden M; Engin K
    Oncol Res Treat; 2017; 40(4):207-214. PubMed ID: 28324876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience.
    Hasan S; Colonias A; Mickus T; VanDeusen M; Wegner RE
    Thorac Cancer; 2018 Jun; 9(6):699-706. PubMed ID: 29697204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.
    Iwata H; Ishikura S; Murai T; Iwabuchi M; Inoue M; Tatewaki K; Ohta S; Yokota N; Shibamoto Y
    Int J Clin Oncol; 2017 Aug; 22(4):706-714. PubMed ID: 28429140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy.
    Klement RJ; Hoerner-Rieber J; Adebahr S; Andratschke N; Blanck O; Boda-Heggemann J; Duma M; Eble MJ; Eich HC; Flentje M; Gerum S; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl KH; Klass ND; Krempien R; Lohaus F; Petersen C; Schrade E; Wendt TG; Wittig A; Guckenberger M
    Radiother Oncol; 2018 May; 127(2):246-252. PubMed ID: 29510865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.